Senisca
Pre-clinicalSENISCA targets the process of cellular ageing (senescence) via the development of RNA senotherapeutics which specifically target the causative molecular mechanisms that drive senescence.
Founded
2018
Employees
11-50
Focus
RNA & Gene Therapy
About
SENISCA targets the process of cellular ageing (senescence) via the development of RNA senotherapeutics which specifically target the causative molecular mechanisms that drive senescence.
Funding History
2Total raised: $2.6M
Seed$1.8MLifeArcMar 15, 2021
Grant$800KInnovate UKSep 15, 2020
Company Info
TypePrivate
Founded2018
Employees11-50
LocationExeter, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile